Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Frontiers in Pharmacology
|
October 7, 2024
Protective effect of MP-40 mitigates BDL-induced hepatic fibrosis by inhibiting the NLRP3-mediated pyroptosis
Xuedong Wan, Yuanyuan Fang, Minjing Qin, et al.
Journal of Neuroinflammation
|
July 21, 2023
Iron induces B cell pyroptosis through Tom20-Bax-caspase-gasdermin E signaling to promote inflammation post-spinal cord injury
Chengjie Wu, Lining Wang, Sixian Chen, et al.
BMC Cancer
|
December 13, 2018
SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
Yibing Chen, Jingjing Zhao, Zhihui Jiao, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik
|
May 30, 2023
Simultaneously mapping loci related to two plant architecture traits by phenotypic recombination BSA/BSR in peanut (Arachis hypogaea L.)
Xiaona Yu, Yaoyao Li, Xinyuan Cui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 2015
Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein
Murali Janakiram, Jordan M Chinai, Susan Fineberg, et al.
Cell Reports
|
December 2, 2014
Structure and cancer immunotherapy of the B7 family member B7x
Hyungjun Jeon, Vladimir Vigdorovich, Sarah C Garrett-Thomson, et al.
Ebiomedicine
|
June 25, 2026
A multi-centre, phase 1a/1b dose escalation and expansion study of the HER2-directed antibody-drug conjugate T-Bren (BL-M07D1) in advanced breast cancer and other solid tumours
Herui Yao, Ruihua Zhao, Xiuping Lai, et al.
International Journal of Cancer
|
November 29, 2022
Feasibility and tolerability of sintilimab plus anlotinib as the second-line therapy for patients with advanced biliary tract cancers: An open-label, single-arm, phase II clinical trial
Shuiling Jin, Ruihua Zhao, Chuang Zhou, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
June 5, 2024
The efficacy and safety of Bazi Bushen Capsule in treating premature aging: A randomized, double blind, multicenter, placebo-controlled clinical trial
Jun Mei, Chunxiao Ju, Biqing Wang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
July 19, 2024
Corrigendum to "The Efficacy and Safety of Bazi Bushen Capsule in Treating Premature Aging: A Randomized, Double Blind, Multicenter, Placebo-controlled Clinical Trial" [Phytomedicine. 2024 Jul 25; 130:155742]
Jun Mei, Chunxiao Ju, Biqing Wang, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Frontiers in Pharmacology
|
October 7, 2024
Protective effect of MP-40 mitigates BDL-induced hepatic fibrosis by inhibiting the NLRP3-mediated pyroptosis
Xuedong Wan, Yuanyuan Fang, Minjing Qin, et al.
Journal of Neuroinflammation
|
July 21, 2023
Iron induces B cell pyroptosis through Tom20-Bax-caspase-gasdermin E signaling to promote inflammation post-spinal cord injury
Chengjie Wu, Lining Wang, Sixian Chen, et al.
BMC Cancer
|
December 13, 2018
SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
Yibing Chen, Jingjing Zhao, Zhihui Jiao, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik
|
May 30, 2023
Simultaneously mapping loci related to two plant architecture traits by phenotypic recombination BSA/BSR in peanut (Arachis hypogaea L.)
Xiaona Yu, Yaoyao Li, Xinyuan Cui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 2015
Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein
Murali Janakiram, Jordan M Chinai, Susan Fineberg, et al.
Cell Reports
|
December 2, 2014
Structure and cancer immunotherapy of the B7 family member B7x
Hyungjun Jeon, Vladimir Vigdorovich, Sarah C Garrett-Thomson, et al.
Ebiomedicine
|
June 25, 2026
A multi-centre, phase 1a/1b dose escalation and expansion study of the HER2-directed antibody-drug conjugate T-Bren (BL-M07D1) in advanced breast cancer and other solid tumours
Herui Yao, Ruihua Zhao, Xiuping Lai, et al.
International Journal of Cancer
|
November 29, 2022
Feasibility and tolerability of sintilimab plus anlotinib as the second-line therapy for patients with advanced biliary tract cancers: An open-label, single-arm, phase II clinical trial
Shuiling Jin, Ruihua Zhao, Chuang Zhou, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
June 5, 2024
The efficacy and safety of Bazi Bushen Capsule in treating premature aging: A randomized, double blind, multicenter, placebo-controlled clinical trial
Jun Mei, Chunxiao Ju, Biqing Wang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
July 19, 2024
Corrigendum to "The Efficacy and Safety of Bazi Bushen Capsule in Treating Premature Aging: A Randomized, Double Blind, Multicenter, Placebo-controlled Clinical Trial" [Phytomedicine. 2024 Jul 25; 130:155742]
Jun Mei, Chunxiao Ju, Biqing Wang, et al.
Page
of 8